Clinical Trial Detail

NCT ID NCT02343666
Title HIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV Infection
Recruitment Withdrawn
Gender
Phase Phase I
Variant Requirements no
Sponsors Fred Hutchinson Cancer Research Center
Indications

Hodgkin's lymphoma

non-Hodgkin lymphoma

Therapies

Filgrastim

Carmustine

Plerixafor

O6-benzylguanine

Age Groups: adult

No variant requirements are available.